Cancer Research AACR Conference on Molecular Diagnostics - 2008  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 1297-1300, December 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albert, D.
Right arrow Articles by Zeidman, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albert, D.
Right arrow Articles by Zeidman, I.

Relation of Glucocorticoid Activity of Steroids to Number of Metastases*

Daniel Albert and Irving Zeidman

( Department of Pathology, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania; and Mt. Desert Island Biological Laboratory, Salisbury Cove, Maine)

Experiments were done to determine whether the effect of steroids in increasing metastases could be correlated with their glucocorticoid or mineralocorticoid activity. 6{alpha}, 9{alpha}-difluoroprednisolone (DFP), cortisone, and deoxycorticosterone (DOC) were tested for effects on metastases produced by intravenous injection of B16 tumor cells in C57/BL6 mice.

Appropriate doses and times of administration were first determined. The maximum steroid effect on metastases appeared in those mice receiving 0.5 mg. of steroid 4–8 hours before the injection of tumor cells. Glucocorticoid activity was also assayed. Both DFP and cortisone increased metastases. DFP was more effective in increasing metastases than was cortisone, and DFP revealed more glucocorticoid activity. DOC did not increase metastases and displayed no glucocorticoid activity. A large dose of DFP did not increase metastases as much as a smaller dose, and the larger dose had less glucocorticoid activity. It is concluded that the capacity of a steroid to increase metastases is correlated with its glucocorticoid activity.

* This investigation was supported by Grants C-2356 and CRT-5022 from the Division of Research Grants and Fellowships of the National Institutes of Health, United States Public Health Service.

Received 6/ 6/62.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.